Home Blog Page 2926

Gorilla Technology Concludes Legal Action Against Culper Research via Settlement Agreement


London, United Kingdom – Newsfile Corp. – July 21, 2025 – Gorilla Technology Group Inc. (NASDAQ: GRRR) (“Gorilla” or the “Company”), today announced that it has resolved its previously disclosed litigation against Culper Research (“Culper”) and its founder, Christian Lamarco.

The Company issued the following statement:

Subsequent to a report published on April 4, 2025 by Culper Research, Gorilla Technology filed a lawsuit against Culper and its founder, Christian Lamarco, on April 16, 2025. Given recent developments, including, but not limited to, the release of Gorilla’s 20F filing dated April 30, 2025 and Gorilla’s earnings release dated June 18, 2025, Gorilla Technology Group and Culper Research have agreed to resolve their litigation via a confidential non-monetary settlement.

Jay Chandan, Chairman & CEO, added:

“We are pleased to put this matter behind us. Gorilla has spent this year doing what matters most, executing our strategy and delivering results. With over $5.6 billion in active pipeline, new capital secured and a growing global customer base, we are not just moving forward, we are accelerating.

The company remains committed to maintaining high standards of transparency and performance as it enters its next phase of growth. This resolution clears the runway, and I intend to use it.”

Gorilla recently hosted a webinar to share updates on its recent momentum, including a $5.6 billion global pipeline of active opportunities and continued U.S. expansion with wide-scale public sector relationships. Moreover, Gorilla’s strong first quarter earnings released on June 18, 2025 reinforce its continued momentum and operational progress. For more information on Gorilla’s business updates, please visit the Company’s investor relations website here.

About Gorilla Technology Group Inc.

Headquartered in London U.K., Gorilla is a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence and IoT technology. We provide a wide range of solutions, including Smart City, Network, Video, Security Convergence and IoT, across select verticals of Government & Public Services, Manufacturing, Telecom, Retail, Transportation & Logistics, Healthcare and Education, by using AI and Deep Learning Technologies.

Our expertise lies in revolutionizing urban operations, bolstering security and enhancing resilience. We deliver pioneering products that harness the power of AI in intelligent video surveillance, facial recognition, license plate recognition, edge computing, post-event analytics and advanced cybersecurity technologies. By integrating these AI-driven technologies, we empower Smart Cities to enhance efficiency, safety and cybersecurity measures, ultimately improving the quality of life for residents.

For more information, please visit our website: Gorilla-Technology.com.

Public Relations Contact:
Samantha Dowd
Prosek Partners
GRRR@prosek.com

Investor Relations Contact:
Dave Gentry
RedChip Companies, Inc.
1-407-644-4256
GRRR@redchip.com

The issuer is solely responsible for the content of this announcement.

About Gorilla Technology Group Inc.

Monarq Asset Management Appoints Sam Gaer as CIO to Lead Directional Strategy

NEW YORK, July 21, 2025 /PRNewswire/ — Monarq Asset Management (“Monarq”), a leading multi-strategy investment firm formerly known as MNNC Group, is pleased to announce the appointment of Sam Gaer as Chief Investment Officer to lead its Directional Investment Strategy. With over 25 years of leadership experience across institutional trading, market infrastructure, and systematic asset management, Sam Gaer brings deep expertise to support Monarq’s next phase of growth.

Following a decade of success in delta-neutral and market-making strategies, Monarq is expanding its directional capabilities to capture a broader range of risk-adjusted returns. The strategy emphasizes high-conviction themes, asymmetric exposures, and tactical volatility overlays—positioning the firm to navigate evolving market conditions with precision.

Monarq’s Directional Strategy has delivered strong performance year-to-date, adhering to disciplined risk and capital allocation. Backed by global institutional capital across its USD and BTC-denominated funds, Monarq is now scaling access to Directional as a complementary source of absolute returns within its platform.

“We’re excited to welcome Sam to the team,” said Shiliang Tang, CEO and Managing Partner. “His leadership enhances our ability to compound asymmetric returns and anticipate key catalysts in the digital asset space.”

Mr. Gaer previously co-managed BlockTower Capital’s flagship fund and founded Katana Financial, a leading systematic trading firm. He also served as CIO at FINRA and EVP/CIO at NYMEX, where he led major technological transformations and strategic initiatives. He holds a degree in Corporate Finance from the Wharton School of the University of Pennsylvania.

About Monarq Asset Management
Monarq Asset Management, formerly MNNC Group, is a multi-strategy digital asset investment manager focused on generating consistent, risk-adjusted returns through all market conditions. Managed by former executives from firms such as LedgerPrime, Tower Research, and BlockTower Capital, the team offers extensive experience in quantitative trading, volatility strategies, and digital market structure.

Media Contact: info@monarq-am.com

FS Investments announces rebrand to “Future Standard,” signaling vision for the next era in private markets

  • Rebrand highlights firm’s evolution, transformational combination with Portfolio Advisors and commitment to delivering differentiated performance
  • New Private Market Outlook urges investors to embrace a more specialized approach to private markets

PHILADELPHIA, July 21, 2025 /PRNewswire/ — FS Investments, an $86 billion global alternative asset manager, today announced its rebrand and renaming to Future Standard. The move marks a major milestone in the firm’s evolution into one of the alternative investment industry’s leading platforms for private equity, credit and real estate investments and solutions.

Future Standard will operate under a unified identity following its transformational combination with Portfolio Advisors, delivering an integrated experience across the firm’s investment strategies. Both firms have long been known as first-movers in the private markets, and the rebrand signals a commitment by the combined firm to remain at the leading edge for clients.

“Future Standard reflects what has always been at our core—a relentless drive to serve clients by uncovering differentiated opportunities that drive performance,” said Michael Forman, Chief Executive Officer. “Our expertise and access enable us to deliver the attractive returns our clients seek by uncovering opportunities others overlook.”

With deep specialization in the U.S. middle market, Future Standard is focused on a segment that is essential to economic growth but remains underrepresented in many investor portfolios. The middle market includes more than 200,000 companies generating between $10 million and $1 billion in annual revenue. As 99% of these companies are privately held, it makes access difficult without the right relationships, expertise and structure.

“In today’s crowded market, standing out demands clarity, conviction and a commitment to challenging convention,” said Stephen Tisdalle, Chief Marketing Officer. “Future Standard reflects how we help optimize our clients’ portfolios with unique and untapped opportunities. This brand gives us the voice and platform to bring our specialization, skill and ambition to our clients and to the entrepreneurs powering the U.S. economy.”

The firm’s new brand leverages its legacy of innovation and industry firsts, including launching the first private business development company (BDC) and the largest non- traded credit REIT. Future Standard’s investment approach combines deep domain expertise with thoughtful product design, providing clients with access to opportunities across liquidity profiles and market cycles.

“While much is changing, the core of who we are and where we operate remains the same,” Forman added. “With specialized teams across asset classes and a strong distribution infrastructure, we are focused on investor outcomes and leading the way in private markets access and performance.”

Private Markets Outlook

Future Standard today also released its latest Private Markets Outlook, “Follow the  Value, Not the Herd,” which examines how policy uncertainty and macroeconomic risks are impacting dealmaking. Beneath this cyclical uncertainty, the report identifies a more significant shift: a new investment imperative is emerging in private markets. Many allocators are flocking to large, brand-name managers—but as the report underscores, capturing real value in this next market phase will require a different approach.

“Nearly half of all private capital raised globally this year has flowed into megafunds, intensifying the challenge of generating attractive returns,” said Mike Kelly, Chief Investment Officer. “We believe the next cycle of alpha will be led by operators who understand how to drive real value—through pricing power, margin expansion, and executional excellence. At a time when policy and geopolitical uncertainty persist, we believe the most compelling opportunities for investors lie in the U.S. middle market, where operational rigor, sector specialization, and manager skill drive differentiated returns.”

In this environment, operational expertise and domain specialization will be the key to outperformance. Future Standard’s analysis shows that in private equity, large-cap managers have underperformed their smaller peers in both median and top-end returns. In both private credit and real estate, smaller funds show greater upside. Meanwhile, higher interest rates are reshaping the investment terrain, compressing equity returns and shifting value toward lenders.

As the global investment landscape evolves, the imperative is clear: managers must think differently and embrace the complexity of what comes next.

Contact information:
Marc Hazelton or Melanie Hemmert 
media@futurestandard.com

ABOUT FUTURE STANDARD

Future Standard is a global alternative asset manager serving institutional and private wealth clients, investing across private equity, credit and real estate. With a 30+ year track record of value creation and over $86 billion in assets under management, we back the business owners and financial sponsors that drive growth and innovation across the middle market, transforming untapped potential into durable value.1

Visit futurestandard.com to learn more.                                  

1 Total AUM estimated as of March 31, 2025.        

Cenra Healthcare and Dr. Reddy’s Strengthen Strategic Partnership to Expand Access to Medicines in Taiwan

TAIPEI, July 21, 2025 /PRNewswire/ — Cenra Healthcare, the sales and marketing arm of Cenra Inc. (TWSE: 3716), today announced the deepening of its long-standing collaboration with the global pharmaceutical company Dr. Reddy’s Laboratories (Taiwan) Ltd (Dr. Reddy’s). Since the partnership began in 2020, the two companies have worked closely to introduce a diverse range of high-quality generic drugs and innovative formulations to patients in Taiwan, with a shared commitment to broadening access to affordable and clinically valuable treatments.

Left – Cenra Healthcare General Manager Lucas Lin; Right – Dr. Reddy’s Group Country Head Satheeshkumar Sriharan.
Left – Cenra Healthcare General Manager Lucas Lin; Right – Dr. Reddy’s Group Country Head Satheeshkumar Sriharan.

“We are proud to strengthen our collaboration with Dr. Reddy’s, one of the world’s leading pharmaceutical companies with strong R&D capabilities,” said Lucas Lin, General Manager of Cenra Healthcare. “With Cenra Healthcare’s broad market coverage and strong presence in Taiwan’s healthcare landscape, we are well positioned to support our partners in promoting access to essential medicines. This partnership is built not just on product alignment, but on a shared belief in patient-centric care — delivering affordable, high-quality treatment options backed by long-term trust and mutual values.”

Over the past five years, Cenra Healthcare and Dr Reddy’s have successfully introduced a number of key therapies in the field of oncology, including chemotherapy agents, hormone therapies, and targeted treatments for prostate cancer, breast cancer, ovarian cancer, and hematological malignancies. The collaboration aligns with the National Health Insurance Administration’s (NHIA) policy to encourage the use of generic drugs in cancer treatment, thereby enhancing medicine supply resilience and safeguarding patient access.

Looking ahead, Cenra Healthcare and Dr. Reddy’s will continue to deepen their partnership by introducing additional  proven therapies across multiple therapeutic areas. Cenra Healthcare is also actively partnering with other leading global pharmaceutical companies to bring more affordable and much-needed medicines to patients in Taiwan – advancing its vision of empowering health equity and delivering hope and trust to patients and families.

About Cenra Healthcare
Cenra Healthcare, established in 2004 as the sales and marketing arm of Cenra Inc., is a leader in providing comprehensive healthcare solutions tailored to meet the diverse needs of individuals in Taiwan and beyond. Cenra Healthcare specializes in the distribution of high-quality pharmaceuticals and innovative healthcare products, ensuring accessibility and affordability for all.

Founded in 1952, Cenra Inc. (TWSE: 3716; formerly China Chemical & Pharmaceutical Co., Ltd.) is one of the leading healthcare companies in Taiwan, with its subsidiaries and affiliates covering a wide range of areas, including human and veterinary pharmaceuticals, active pharmaceutical ingredients, health supplements, over-the-counter (OTC) drug products, household and beauty products, and elderly care services. Cenra is driven by a vision of “Empowering health equity, propelling a healthier world for all,” and is committed to delivering impactful health solutions and enhancing public health through partnerships and strategic alliances. For more information, please visit cenra.com.

About Dr. Reddy’s
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) was founded in 1984 and is headquartered in Hyderabad, India. Guided by its mission ‘Good Health Can’t Wait’, it is committed to providing affordable and innovative medicines. Its portfolio of products and services includes active pharmaceutical ingredients (APIs), generics (including biosimilars and OTC products), innovative products, and custom pharmaceutical services. Its key therapeutic focus areas are gastrointestinal, cardiovascular, and oncology. Dr. Reddy’s has a global presence spanning over 80 countries, with major markets including the United States, India, Russia & other CIS countries, China, Brazil, and Europe.

Shanghai Healthcare M&A Fund Strategically Acquires Chengdu Kanghua Biological, Establishing a Fully Integrated Ecosystem


HONG KONG SAR – Media OutReach Newswire – 21 July 2025 – Chengdu Kanghua Biological Products Co., Ltd. (Stock Code: 300841.SZ) announced that Shanghai Healthcare M&A Fund (“the M&A Fund”) intends to acquire the Company through a strategic agreement. Leveraging its substantial resource and financial strength, the M&A Fund plans to support Kanghua Biological’s established product portfolio, accelerate sales of its mature products, and develop industry synergies between Shanghai and Chengdu. The goal is to rapidly expand a diversified vaccine pipeline and build an integrated vaccine ecosystem that combines proven commercialized products with best-in-class R&D capabilities.

Shanghai Healthcare M&A Fund Strategically Acquires Chengdu Kanghua Biological
Shanghai Healthcare M&A Fund Strategically Acquires Chengdu Kanghua Biological

Dual-Driven Strategy: “Commercialization + Innovation” to Build a Leading Vaccine Ecosystem
The vaccine industry is an essential pillar of public health with high entry barriers, stringent oversight, and extended development cycles – all factors contributing to its significant growth potential. As a leading domestic vaccine producer, Kanghua Biological’s flagship product – human diploid cell rabies vaccine – stands as China’s first domestically developed premium vaccine with over a decade of safe application, established market presence and nationwide distribution. The Company also maintains a robust global innovation pipeline, having successfully licensed its recombinant hexavalent norovirus vaccine overseas. This strategic acquisition, focused on critical segments of the vaccine value chain, will strengthen its strategic positioning. The M&A Fund is committed to supporting Kanghua Biological in leveraging its core product line while harnessing the combined strengthens of Shanghai and Chengdu to accelerate the formation of a next-generation vaccine industry ecosystem.

Twin-City Collaboration: Combining “R&D + Manufacturing” to Create a New Industrial Framework
This acquisition marks a significant step to drive Shanghai and Chengdu biopharmaceutical cooperation. Post-transaction, Kanghua Biological will capitalize on Shanghai’s advanced R&D resources and access to top-tier scientific talent and global capital to enhances its industrial capabilities, manufacturing capacity, and market penetration. The M&A Fund will consolidate diverse industrial assets to promote Kanghua Biological’s integration with Shanghai’s R&D and clinical networks, creating an end-to-end collaborative system that spans from “clinical R&D to commercialization” and accelerates the development of a full industrial value chain.

Dual-Channel Empowerment: Driving Corporate Value through “M&A + Integration”
“This transaction goes beyond a typical corporate acquisition, it represents a transformative catalyst for industrial upgrading,” commented Li Chen, Co-President of the M&A Fund. “This exemplifies the complementary strengths created by resource-empowered consolidation. With deep biopharmaceutical, financial, R&D, and global network expertise, Shanghai Healthcare M&A Fund will create significant synergies with Kanghua Biological’s technologies, products, manufacturing, and domestic distribution to have an outsized impact on the sector.”
Hashtag: #SIICCapital #ChengduKanghuaBiological #ShanghaiHealthcareM&AFund

The issuer is solely responsible for the content of this announcement.

About Shanghai Healthcare M&A Fund

A core component of Shanghai’s state-owned capital fund network, Shanghai Healthcare M&A Fund is managed by SIIC Capital, a subsidiary of SIIC Group. The M&A Fund targets Shanghai’s biopharmaceutical sector, aligning government policy objectives with industrial needs by fostering collaboration with leading industry companies, strengthening sector clusters, and enabling asset restructuring. Through capital infusion, improving governance, optimizing management, and executing M&A, the M&A Fund backs “anchor” companies to build complementary and reinforcing links in the value chain, driving the ongoing transformation of specialized subsectors.

About Chengdu Kanghua Biological Products Co., Ltd.

Chengdu Kanghua Biological Products Co., Ltd. is a biopharmaceutical company engaged in research, manufacture and commercialization of biological products. Established in 2004, the company operates an in-house testing center and GMP-certified bacterial and viral vaccine production facilities. Its marketed portfolio includes the ACYW135 meningococcal polysaccharide vaccine and a freeze-dried human diploid cell rabies vaccine. Kanghua holds GMP certification from China’s National Medical Products Administration, has participated in numerous scientific research projects and has been granted patents for over 100 technologies.

Multiplier Wins Gold and Silver Stevie® Awards for Redefining Global Hiring

The company was awarded Gold for HR Technology Solution Provider of the Year and Silver for Global HR Solution Provider of the Year.

NEW YORK, July 21, 2025 /PRNewswire/ — Multiplier, a leading global employment platform, today announced it has been honored with both a Gold Stevie® Award for HR Technology Solution Provider of the Year and a Silver Stevie® Award for Global HR Solution Provider of the Year in the prestigious 10th annual Stevie® Awards for Great Employers. These accolades recognize Multiplier’s pivotal role in transforming how companies access, manage, and scale global talent.

The Stevie® Awards are the world’s premier business awards, celebrating excellence in the workplace across a wide range of industries and functions. This recognition reflects Multiplier’s impact in democratizing global hiring, making it accessible, cost-effective, and compliant for companies worldwide.

“We’ve always believed that talent knows no borders,” said Sagar Khatri, Co-founder and CEO of Multiplier. “The Stevie Awards are a powerful validation of the technology we’ve built at Multiplier to turn that belief into reality. We’re removing the friction from global hiring, and giving companies the tools to scale across markets with speed and confidence.”

Since its inception in 2020, Multiplier has been on a mission to simplify the complexities of international hiring. The company’s platform helps businesses to onboard, manage, and pay employees and contractors across more than 150 countries and in over 120 currencies. Through a single, automated, and compliance-first solution, Multiplier significantly reduces the total cost of ownership by up to 35% and provides unparalleled support with dedicated Customer Success Managers and 24/7 human-led assistance.

The Gold Stevie® Award for HR Technology Solution Provider of the Year specifically highlights Multiplier’s cutting-edge platform, lauded for its intuitive, AI-led user experience that streamlines global hiring and payroll processes. The Silver Stevie® Award for Global HR Solution Provider of the Year acknowledges the company’s broader impact in enabling frictionless international expansion for businesses of all sizes, fundamentally changing the landscape of global employment.

“Multiplier doesn’t just tick the innovation boxes; it was born from real-world frustration and built with human empathy at its core,” said one of the Stevie Award Judges. “The awards and recognitions (IEC, Everest, G2, Fast Company) are impressive, but the real strength lies in how they’ve quietly redefined what global employment feels like: fast, compliant, and deeply people-first.”

Details about the Stevie Awards for Great Employers and the list of 2025 Stevie winners

are available at www.StevieAwards.com/HR.

END

About Multiplier

Multiplier is a global employment platform for HR leaders and professionals who need an easy, fast, and cost-effective way to onboard, hire, manage and pay the best global talent across 150+ countries. Through its best-in-class EOR, COR, Global Payroll, and compliance technology, plus person-to-person support and hyper-local employee benefits, Multiplier empowers its customers to hire the best global talent and build a world of limitless opportunity.

About the Stevie Awards

Stevie Awards are conferred in nine programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards®, The International Business Awards®, the Stevie Awards for Great Employers, the Stevie Awards for Women in Business, the Stevie Awards for Technology Excellence and the Stevie Awards for Sales & Customer Service. Stevie Awards competitions receive more than 12,000 entries each year from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com.

 

DCA Opens Today to Strengthen Asia’s Data Centre Network

HONG KONG, July 21, 2025 /PRNewswire/ — Data Center Asia (DCA) debuts today at AsiaWorld-Expo, Hong Kong, marking the exciting launch of a new force in the APAC data center landscape. Built on the proven success of the Data Center World event in the United States, DCA brings global expertise to Asia while tailoring the experience to meet the needs of regional markets. Starting with its flagship edition in Hong Kong — the gateway to Greater China and Northeast Asia — the series will move on to Jakarta and Kuala Lumpur in Southeast Asia, creating a truly connected platform for Asia’s data center ecosystem.

All-in-One Solution Showcase and Knowledge Hub

The inaugural edition brings together over 200 brands from across China, Singapore, Japan, the United States and beyond. Exhibits span the full spectrum of data center infrastructure — from power and cooling technologies, modular designs, network equipment to security solutions, cloud and virtualization technologies, DCIM and sustainability practices. A standout feature is the MATRADE Pavilion, showcasing cutting-edge digital innovations from some of Malaysia’s leading technology companies.

Serving as both an exhibition and an industry think tank, the expo presents five summits and forums over the three days, exploring 12 key themes such as AI, sustainability, cybersecurity, computing advancements and more. More than 100 global thought leaders, researchers and analysts lead curated sessions developed with our content partners, delivering data-driven insights to inform real-world decisions.

Omdia Leads the AI Dialogue at DCA 2025

As a key brand under Informa Markets’ TechTarget portfolio, Omdia is a trusted research and advisory group in the global tech industry. Serving clients across 180 countries, Omdia draws on vast datasets to support technology innovation from R&D to return on investment.

Omdia Analyst Summit — a premier event within the US exhibition — returned as an exclusive full-day conference at DCA 2025. Centered on the theme “Where is AI Really Headed?”, the summit guided in-depth discussions on AI’s role in transforming data centers by 2030, with data-backed insights on how AI optimize cooling systems and accelerate demand for alternative energy solutions.

Forum Spotlights Carbon-Neutral Initiatives

The concurrent track presents the Sustainability Forum, which delved into strategies for achieving carbon neutrality in data centers. The opening keynote by Pritesh Swamy, Head of Data Centre Research & Advisory, Asia Pacific, Cushman & Wakefield, outlined investment opportunities in the data centers across Asia Pacific, driven by ESG performance & energy efficiency. Another key session featured association leaders from Malaysia, Singapore and the Philippines, offering long-term data center design strategies tailored to Southeast Asia.

Unlock Targeted Insights Across Sectors

DCA offered a rich line-up of events over the rest two days, all providing specialized insights and focused learnings to attendees. The Deep Knowledge Summit, co-hosted with Deep Knowledge Community and E7 Research, featured keynote speakers including Yin Jianxiong, Solution Architect and Director of Nvidia-SEA Joint Lab and Zhang Peng CTO, SLiquid Global and Jung-hyup Kang, President of Korea Data Center Council to explore integration of AI and green technologies in data center architecture and operations.

The Cybersecurity Ecosystem Forum, co-hosted with ISC2 Shanghai Chapter, addresses cybersecurity challenges in the AI era including data privacy, skills gaps, cross-border data flows and zero-trust security. Featured speakers include Judy Saw, President of Digital Defence Alliance Singapore (DDAS); Patrick Wong, Partner of Cybersecurity and Privacy of PwC and Ricky Chau, Chief Strategy & Customer Officer of CBC Tech.

The Design & Operations Summit examined data center construction and management, from site selection to design, construction and operations. Poh Seng Lee, Head of Mechanical Engineering and Professor of Thermal Systems at the National University of Singapore, leaded discussions on building AI-ready data centers and Wei Lulu, Deputy General Manager of Data to Cool (DTC) offered the latest innovations on liquid cooling technology.

Connected Intelligence at DCA 2025

DCA took place under the license of Build4Asia, Asia’s premier platform for building, electrical engineering and security solutions, alongside Mobility Tech Asia and the Battery Show Asia. This collaboration offered a comprehensive perspective on data innovation and application, bringing together IDC experts, EPC contractors, data center infrastructure manufacturers, distributors, end users and more for valuable cross-sector exchange.

As Asia’s only event of its kind, DCA delivered a complete data center experience through top-tier exhibits, thought-leading conferences and tailored networking. Industry professionals can engage with advanced technologies, uncover practical insights, and establish high-value partnerships — all within one single platform that offers regional focus with global ambition.

DCA is open to trade professionals and media only and visitors must be aged 18 or above. Registering for DCA provides entry to the full line-up of co-located events.

For snapshots of Data Centre Asia Hong Kong, please visit:
https://informa-markets.gump.gg/album/build4asia-data-center-asia

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.

Sahm Capital Ignites Financial Ambition in University Students with “Investing 101” Masterclass

Interactive lecture empowers the next generation of Saudi investors with practical tools, confidence, and real-time trading activation


RIYADH, SAUDI ARABIA – Media OutReach Newswire – 21 July 2025 – Sahm Capital empowered Alfaisal University students through its on-campus masterclass, “Investing 101: How to Start Trading & Build Wealth Intelligently.” Led by Huma Ejaz, Vice President of Advisory and Asset Management, the two-hour session delivered practical, engaging financial education aligned with Sahm Capital’s mission to cultivate a financially literate generation of Saudi investors.

The lecture combined foundational investing principles with live demonstrations and real-world insights into Saudi Arabia’s capital market. Students explored essential topics including asset classes, how to open and manage a trading account locally, and the habits of disciplined, long-term investors. The interactive Q&A segment invited students to raise individual concerns, demonstrating their eagerness to understand and apply the knowledge in real life.

The session was further enriched by a gamified quiz covering core concepts such as risk, markets, and investing behavior. Top-performing students were celebrated with exclusive Sahm Capital gift boxes, while dozens of attendees activated their Sahm accounts on-site with support from the company’s team. Participating students received Sahm-branded gift bags to mark the beginning of their investing journey.

The event was met with enthusiastic feedback from students, with one participant commenting “Learning directly from an expert showed me how to start building wealth today—I never thought investing could be this approachable.” Another shared, “This gave me clarity, confidence, and real tools. I’m opening my first trading account with Sahm.”

“Seeing this level of engagement is exactly why we invest in education,” said Huma Ejaz. “We replaced hesitation with hands-on experience. These students didn’t just learn—they acted.”

This initiative is part of Sahm Capital’s broader strategy to foster investor readiness and financial literacy among young Saudis. By delivering engaging workshops, digital resources, and on-ground activation, Sahm Capital actively supports the goals of Vision 2030—cultivating a generation of disciplined, confident investors ready to participate in the Kingdom’s capital market.

Hashtag: #SahmCapital #CMA#Tadawul




The issuer is solely responsible for the content of this announcement.

Sahm Capital

Sahm Capital, registered in Riyadh, holds full regulatory licenses from the Capital Market Authority (CMA) to provide Dealing, Advising, Custody, Arranging, and Managing Investments and Operating Funds Activities in the Securities Business services (license no. 22251-25). As the first fintech-driven financial company to achieve full CMA licensing, Sahm Capital has established itself as the fastest-growing member of the Saudi Exchange, leveraging proprietary technology and innovative financial solutions to deliver seamless, one-stop financial services. For more information, visit: www.sahmcapital.com